Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Niemann-Pick C1 receptor (NPC1)–Zaire ebolavirus glycoprotein (GP) interaction is a critical protein-protein complex that facilitates Ebola virus entry into host cells during infection. Zaire ebolavirus GP, a trimeric class I viral fusion protein on the virion surface, mediates initial attachment via its GP1 subunit and subsequent membrane fusion via GP2, with NPC1 serving as the essential endosomal receptor that binds the primed GP after cathepsin cleavage removes the glycan cap and mucin-like domain. This interaction occurs in the late endosome, where NPC1's C-terminal domain engages a hydrophobic cavity on GP1, triggering conformational changes that drive fusion loop insertion into the host membrane and viral genome release. The GP trimer forms a chalice-like structure in its prefusion state, with GP1 forming the bowl that sequesters the receptor-binding site until proteolytic priming exposes it for NPC1 engagement. This process is central to filovirus pathogenesis, enabling immune evasion through heavy glycosylation and restricting neutralizing antibody access. Targeting this interaction holds therapeutic potential for blocking Ebola entry, though no approved drugs directly inhibit it; instead, it informs antibody and small-molecule strategies against viral fusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Niemann-Pick C1 receptor–Zaire ebolavirus glycoprotein interaction.